"Pretreatment neutrophil-to-lymphocyte ratio seems to represent a reliable simple and easy to reproduce laboratory tool to predict outcome and response to cancer therapies in this setting of Western Caucasian patients with EGFR-mutated on-small-cell lung cancer"xsd:string